Testing effectiveness (Phase 2)Study completedNCT00487708
What this trial is testing
Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms
Who this might be right for
NALP3 Mutation
Novartis Pharmaceuticals 34